Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) EBT (2016 - 2025)

Historic EBT for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$1.3 million.

  • Biomerica's EBT fell 3798.53% to -$1.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$4.0 million, marking a year-over-year increase of 2819.6%. This contributed to the annual value of -$5.0 million for FY2025, which is 1623.99% up from last year.
  • As of Q4 2025, Biomerica's EBT stood at -$1.3 million, which was down 3798.53% from $5000.0 recorded in Q3 2025.
  • Biomerica's 5-year EBT high stood at $5000.0 for Q3 2025, and its period low was -$2.1 million during Q1 2021.
  • For the 5-year period, Biomerica's EBT averaged around -$1.4 million, with its median value being -$1.5 million (2021).
  • In the last 5 years, Biomerica's EBT tumbled by 149144.66% in 2023 and then skyrocketed by 10038.11% in 2025.
  • Biomerica's EBT (Quarter) stood at -$1.1 million in 2021, then tumbled by 44.72% to -$1.6 million in 2022, then rose by 7.75% to -$1.5 million in 2023, then skyrocketed by 36.42% to -$953000.0 in 2024, then plummeted by 37.99% to -$1.3 million in 2025.
  • Its EBT stands at -$1.3 million for Q4 2025, versus $5000.0 for Q3 2025 and -$1.5 million for Q2 2025.